In blood cancer (OS: total number = 58, HR = 1.33, Cox P = 0.014354), brain cancer (OS: total number = 74, HR = 3.52, Cox P = 0.002613) and breast cancer [RFS (relapse-free survival): total number = 60, HR = 1.64, Cox P = 0.034006; DMFS (distant metastasis-free survival): total number = 286, HR = 0.69, Cox P = 0.040377], CFP played a detrimental role. This evidence concerns the gene CFP and breast carcinoma.